Close X
Thursday, February 27, 2025
ADVT 
International

Flood situation in Pak highly likely to boost disease spread: WHO

Darpan News Desk IANS, 01 Sep, 2022 11:13 AM
  • Flood situation in Pak highly likely to boost disease spread: WHO

Islamabad, Sep 1 (IANS) The catastrophic flood situation in Pakistan will highly likely increase the spread of disease, says the World Health Organization (WHO), as the country continues its relentless battle against the deadly deluges.

In its latest situation report on flooding in Pakistan, the WHO pointed out that the heavy monsoon rain which started in mid-June are continuing in many parts of the country and have affected 116 districts (75 per cent) out of the total 160, Geo News reported.

The most affected province is Sindh, followed by Balochistan.

As of August 25, more than 33 million people have been affected and over 6.4 million people are in dire need of humanitarian aid, including 421,000 refugees, the WHO report highlighted.

More than 1,100 lives have been lost and almost 15,000 people injured.

The WHO report focused on what it called the "severe" impact on health facilities, stating that as of August 28, 888 health facilities have been damaged in the country of which 180 of them are completely damaged.

Photo courtesy of IANS. 

"Access to health facilities, health care workers, and essential medicines and medical supplies remain the main health challenges for now," Geo News quoted the WHO report as saying.

Pakistan's health system is already battling multiple concurrent health threats, including Covid-19, and outbreaks of cholera, typhoid, measles, leishmaniasis and HIV, the WHO said, adding that even before the current floods, there was a significant disparity in access to health services between rural and urban areas.

Meanwhile, health experts have sounded the alarm regarding the outbreak of disease in flood-affected areas, estimating around five million people to fall sick in the next four to 12 weeks.

MORE International ARTICLES

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK